Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1970 Sep;24(3):548–553. doi: 10.1038/bjc.1970.66

Protection from the Embryopathic Effects of 7-Hydroxymethyl-12-Methylbenz(a)Anthracene by 2-Methyl-1,2-bis-(3-Pyridyl)-1-Propanone (Metopirone,CIBA) and β-Diethylaminoethyldiphenyl-n-Propyl Acetate (SKF 525-A)

C C Bird, Allison M Crawford, A R Currie, B Fiona Stirling
PMCID: PMC2008608  PMID: 5479302

Abstract

Pretreatment with Metopirone (40 mg.) or SKF 525-A (2 mg./100 g. maternal body weight) protected aganist the embryotoxic and teratogenic actions of7-OHM-12-MBA) (2.5 mg/100 g. maternal body weight) in the Sprague-Dawley rat. At the doses administered SKF-525-A was a more efficient protector than Metopirone. The adrenocorticolytic actions of 7-OHM-12-MBA in the maternal adrenal glands were also prevented by these compounds and a close correlation existed between the degree of protection of the maternal adrenals and of the foetuses. It is suggested that the ultimate embryopathic substance is a metabolite of 7-OHM-12-MBA.

Full text

PDF
548

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyland E., Sims P., Huggins C. Induction of adrenal damage and cancer with metabolites of 7,12-dimethylbenz(a)anthracene. Nature. 1965 Aug 21;207(999):816–817. doi: 10.1038/207816b0. [DOI] [PubMed] [Google Scholar]
  2. CHART J. J., SHEPPARD H., ALLEN M. J., BENCZE W. L., GAUNT R. New amphenone analogs as adrenocortical inhibitors. Experientia. 1958 Apr 15;14(4):151–152. doi: 10.1007/BF02157133. [DOI] [PubMed] [Google Scholar]
  3. CURRIE A. R., HELFENSTEIN J. E., YOUNG S. Massive adrenal necrosis in rats caused by 9,10-dimethyl-1,2-benzanthracene and its inhibition by metyrapone. Lancet. 1962 Dec 8;2(7267):1199–1200. doi: 10.1016/s0140-6736(62)90966-2. [DOI] [PubMed] [Google Scholar]
  4. Jellinck P. H., Garrett T. Metabolism of metopirone and 3-(1,2,3,4-tetrahydro-1-oxo-2 naphthyl)-pyridine in relation to DMBA induced adrenal necrosis. Experientia. 1969 Aug 15;25(8):799–800. doi: 10.1007/BF01897883. [DOI] [PubMed] [Google Scholar]
  5. WONG T. W., WARNER N. E. INHIBITION OF DIMETHYLBENZANTHRACENE-INDUCED ADRENAL CORTICAL NECROSIS. Endocrinology. 1964 Feb;74:284–289. doi: 10.1210/endo-74-2-284. [DOI] [PubMed] [Google Scholar]
  6. Wheatley D. N. Action of drugs affecting the functioning of the adrenal cortex on adrenal necrosis induced by 7,12-dimethylbenz(alpha)anthracene and its 7-hydroxymethyl derivative in rats. Endocrinology. 1968 Jun;82(6):1217–1222. doi: 10.1210/endo-82-6-1217. [DOI] [PubMed] [Google Scholar]
  7. Wheatley D. N., Sims P. Comparison of the efficacy of pretreatment protection against adrenal necrosis induced by 7-hydroxymethyl-12-methylbenz(a)anthracene and by 7-methyl-12-methylbenz(a)anthracene in rats. Biochem Pharmacol. 1969 Oct;18(10):2583–2587. doi: 10.1016/0006-2952(69)90377-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES